Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Raymond James Financial (RJF) Research & Development (2016 - 2025)

Raymond James Financial (RJF) has disclosed Research & Development for 17 consecutive years, with $81.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 19.12% year-over-year to $81.0 million, compared with a TTM value of $304.0 million through Dec 2025, up 275.31%, and an annual FY2025 reading of $291.0 million, up 13.23% over the prior year.
  • Research & Development was $81.0 million for Q4 2025 at Raymond James Financial, down from $82.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $354.0 million in Q3 2021 and bottomed at -$224.0 million in Q3 2024.
  • Average Research & Development over 5 years is $81.5 million, with a median of $76.5 million recorded in 2024.
  • The sharpest move saw Research & Development surged 297.14% in 2022, then tumbled 241.77% in 2024.
  • Year by year, Research & Development stood at $35.0 million in 2021, then soared by 297.14% to $139.0 million in 2022, then increased by 7.91% to $150.0 million in 2023, then plummeted by 54.67% to $68.0 million in 2024, then increased by 19.12% to $81.0 million in 2025.
  • Business Quant data shows Research & Development for RJF at $81.0 million in Q4 2025, $82.0 million in Q3 2025, and -$43.0 million in Q2 2025.